Boehringer Ingelheim

Boehringer details data from pair of Phase III pulmonary fibrosis wins
First Word Pharma
Mon, 05/19/25 - 10:28 pm
Boehringer Ingelheim
pulmonary fibrosis
clinical trials
nerandomilast
Boehringer Ingelheim Starts Phase II Study of its Potential First-in-Class Oral Compound as a Treatment for Geographic Atrophy​
Drugs.com
Tue, 05/6/25 - 09:34 pm
Boehringer Ingelheim
clinical trials
BI 1584862
geographic atrophy
Boehringer to expand oncology presence with $572m Tessellate Bio deal
Pharmaceutical Technology
Wed, 04/23/25 - 09:42 am
Boehringer Ingelheim
Tessellate Bio
cancer
oncology
telomeres
Boehringer reports 6% sales growth for 2024
The Pharma Letter
Wed, 04/2/25 - 11:23 am
Boehringer Ingelheim
earnings
Zantac Lawsuit: Illinois Jury Rules in Favor of Boehringer Ingelheim
Lawyer Monthly
Tue, 02/25/25 - 10:41 pm
Boehringer Ingelheim
Zantac
Illinois
prostate cancer
legal
Boehringer and partners commence gene therapy trial for cystic fibrosis
Clinical Trials Arena
Fri, 02/21/25 - 10:49 am
Boehringer Ingelheim
gene therapy
cystic fibrosis
clinical trials
Boehringer eyes third quarter FDA verdict for oral HER2 drug
Pharmaphorum
Thu, 02/20/25 - 11:29 am
Boehringer Ingelheim
zongertinib
FDA
metastatic non-small cell lung cancer
ExpressionEdits and Boehringer Ingelheim partner to optimize gene therapies
Pharmaceutical Business Review
Fri, 02/14/25 - 09:15 am
Boehringer Ingelheim
ExpressionEdits
gene therapy
Boehringer's phase 3 schizophrenia program misses primary goal
Fierce Biotech
Thu, 01/16/25 - 09:39 pm
Boehringer Ingelheim
schizophrenia
clinical trials
iclepertin
Boehringer Ingelheim drops obesity drug from Gubra partnership
Fierce Biotech
Thu, 10/31/24 - 10:45 pm
Boehringer Ingelheim
Gubra
obesity
Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug
Fierce Biotech
Tue, 10/15/24 - 10:17 am
Notable Labs
Boehringer Ingelheim
oncology
bankruptcy
volasertib
Boehringer unveils $607M deal to land Circle's preclinical cancer program
Fierce Biotech
Wed, 10/9/24 - 09:55 am
Boehringer Ingelheim
Circle Pharma
cancer
drug development
Boehringer kickstarts two Phase III trials as MASH therapy wins breakthrough status
Clinical Trials Arena
Tue, 10/8/24 - 09:56 am
Boehringer Ingelheim
MASH
clinical trials
survodutide
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tue, 10/8/24 - 09:45 am
R&D
obesity
weight loss
Novo Nordisk
Eli Lilly
Roche
Boehringer Ingelheim
Boehringer Ingelheim and Veeva: A data partnership for One Medicine
Pharmaphorum
Fri, 10/4/24 - 09:18 am
Boehringer Ingelheim
Veeva
One Medicine Platform
Clinical Data
Boehringer's phase 3 lung fibrosis trial hits primary endpoint, teeing up filings for Ofev successor
Fierce Biotech
Mon, 09/16/24 - 10:57 am
Boehringer Ingelheim
IPF
clinical trials
nerandomilast
Boehringer Ingelheim reports positive results from trial of HER2 lung cancer drug
Clinical Trials Arena
Tue, 09/10/24 - 08:35 am
Boehringer Ingelheim
clinical trials
zongertinib
non-small cell lung cancer
Boehringer adds to cancer drug pipeline with deal for startup Nerio
BioPharma Dive
Mon, 07/29/24 - 11:01 am
Boehringer Ingelheim
M&A
Nerio Therapeutics
immuno-oncology
GoodRx teams with Boehringer on Humira biosimilar
Axios
Thu, 07/18/24 - 11:21 am
GoodRx
Boehringer Ingelheim
biosimilars
Humira
Boehringer backs Brainomix AI software for lung fibrosis
Pharmaphorum
Thu, 07/18/24 - 11:08 am
Boehringer Ingelheim
digital health
lung fibrosis
Brainomix
artificial intelligence

Pages